relative to strengthening prescription drug affordability and pharmacy benefits manager accountability.
Pending Motion Interim Study; 03/12/2026; SJ 6
Email me when SB 478 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SB 478. By continuing you agree to the Terms and Privacy Policy.
Summary
The measure would stop pharmacy benefit managers (PBMs) from keeping the difference between what they are paid and the actual drug cost, require all manufacturer rebates to be used to reduce premiums or out‑of‑pocket prices, and make PBM fees independent of drug prices. It also adds reporting rules, caps insulin copays, and gives consumers an option to spread high pharmacy bills over the year. The goal is to make prescription drugs more affordable and to make PBM practices clearer to insurers and patients.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SB 478
3 free questions a day, no accountHistory
- Sen. Rochefort Moved Laid on Table, MA, VV; 03/12/2026; SJ 6
- SB 478 was Removed from the Consent Calendar; 03/12/2026; SJ 6
- Pending Motion Interim Study; 03/12/2026; SJ 6
- Committee Report: Referred to Interim Study, 03/12/2026; Vote 4-1; CC; SC 9
- Hearing: 01/21/2026, Room 100, SH, 01:45 pm; SC 2
- Introduced 01/07/2026 and Referred to Health and Human Services; SJ 1
Sponsors
- Tim McGough (R) · sponsor
- Bill M. Gannon
- Brian D Cole
- Cindy Rosenwald
- Daniel E. Innis
- Howard Pearl
- John Michael Potucek
- Julie Miles
- Lilli M Walsh
- Regina Birdsell
- Wayne D. MacDonald
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SB 478 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 478 freeOr ask your AI assistant about SB 478 directly:
Add to Claude, ChatGPT or Cursor